CD44 family proteins in gastric cancer: a meta-analysis and narrative review

scientific article published on 15 March 2015

CD44 family proteins in gastric cancer: a meta-analysis and narrative review is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID4443089
P698PubMed publication ID26064255

P2093author name stringYunpeng Liu
Kai Yu
Shuang Wang
Ying Wu
Chenlu Zhang
Zhi Li
Lei Cui
Xiaosong Yu
Guoliang Zheng
Zan Teng
P2860cites workCD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growthQ24296787
Global cancer statistics, 2002Q27860562
Extracting summary statistics to perform meta-analyses of the published literature for survival endpointsQ27860640
Practical methods for incorporating summary time-to-event data into meta-analysisQ28131754
Mechanism and biological significance of CD44 cleavageQ28298070
Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancerQ31789296
Molecular studies into the role of CD44 variants in metastasis in gastric cancerQ33706667
Clinical and prognostic significance of HIF-1α, PTEN, CD44v6, and survivin for gastric cancer: a meta-analysisQ35125058
Sequential expression of putative stem cell markers in gastric carcinogenesisQ35287614
Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinomaQ35577863
Frequent gene amplification predicts poor prognosis in gastric cancerQ35933994
Molecular-pathological prognostic factors of gastric cancer: a reviewQ36112136
Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancerQ36616818
CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence.Q37040620
Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinomaQ37234183
Cancer stem cell markers in common cancers - therapeutic implicationsQ37262517
Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatmentQ38212216
Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation.Q39044097
Identification of gastric cancer stem cells using the cell surface marker CD44.Q39856772
The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric CancerQ39866556
De-novo expression of CD44 and survival in gastric cancerQ42483834
Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virusQ44182041
[Expression tumor stem cell surface marker CD44 in gastric cancer and its significance].Q45927908
Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinomaQ46051896
Prognostic significance of CD44 and c-erb-B2 protein overexpression in patients with gastric cancer.Q54447886
Expression of CD44 variant exons 8-10 in gastric cancer.Q55005136
Correlation between nm23 protein and several cell adhesion molecules in human gastric carcinoma.Q55255520
Expression of CD44 and Its Clinical Implication in Diffuse–Type and Intestinal–Type Gastric AdenocarcinomasQ58828380
Immunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancerQ71707536
Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progressionQ73072089
Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancerQ73923952
Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progressionQ74563009
Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinomaQ77308619
Expression of cell adhesion molecule CD44 and sialyl Lewis A in gastric carcinoma and colorectal carcinoma in association with hepatic metastasisQ77410201
Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinomaQ77853317
Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancerQ82142859
Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancerQ83239273
Prognostic impact of CD133 expression in gastric carcinomaQ84586885
Gastric cancer: basic aspectsQ84899615
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)3595-3606
P577publication date2015-03-15
P1433published inInternational Journal of Clinical and Experimental MedicineQ6051338
P1476titleCD44 family proteins in gastric cancer: a meta-analysis and narrative review
P478volume8

Reverse relations

cites work (P2860)
Q33728237A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer
Q38601789Cancer stem cells in human digestive tract malignancies
Q35955938Long Non-Coding RNA ucoo2kmd.1 Regulates CD44-Dependent Cell Growth by Competing for miR-211-3p in Colorectal Cancer
Q38845190Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance
Q92073923Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence
Q40435121Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer
Q37564476Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses
Q37479140SALL4 promotes gastric cancer progression through activating CD44 expression